跳至主要内容
临床试验/JPRN-jRCTs041220150
JPRN-jRCTs041220150招募中2 期

Phase II study of dynamic intensity modulated radiotherapy in patients with borderline resectable pancreatic cancer - Phase II GS-IMRT trial

Mizuno Shugo0 个研究点目标入组 42 人开始时间: 2023年3月1日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 79age old(—)
性别
All

入选标准

  • 1. age at the time of registry is 20 o r more, 79 or less
  • 2. newly diagnosed invasive pancreatic ductal adenocarcinoma (PDAC) confirmed by imaging study and histological or cytological studies.
  • 3. no distant metastasis
  • 4. borderline resectable PDAC according to the resectability of Japan Pancreas Society 7th classification based on contrast enhanced multid etector CT imaging.
  • 5. toleable curative resection
  • 6. no previous anti-tumor treatment
  • 7. Eastern Cooperative Oncology G roup performance status, 0, 1
  • 8. adequate hematological, hepatic, renal, and cardiopulmonary functions
  • 9. adequate ability of oral intake
  • 10. written informed consent befor e enrolling the study

排除标准

  • Patients who:
  • 1) is allergic to the chemotherapeutic agents.
  • 2) has pulmonary fibrosis or intestinal pneumonia.
  • 3) has active infectious disease.
  • 4) has simulatenous active cancer.
  • 5) is plegnant or has possibility to become pregnant during the study.
  • 6) is considered ineligible for enrolling the study by the principal investigator or sub-investigator.

研究者

发起方
Mizuno Shugo

相似试验